𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of prophylactic salpingo-oophorectomy in women who carry mutations of the BRCA genes

✍ Scribed by S Eliza Griffiths; Tito Lopes; Richard J Edmondson

Book ID
111838147
Publisher
Royal College of Obstetricians and Gynaecologists
Year
2005
Weight
94 KB
Volume
7
Category
Article
ISSN
1467-2561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prophylactic salpingo-oophorectomy in a
Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
✍ Fatima Laki; Youlia M. Kirova; Pascale This; for the IC-BOCRSG ; Corinne Planche πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract ## BACKGROUND. Prophylactic salpingo‐oophorectomy (SO), which is recommended in __BRCA1/2__ mutation carriers, still needs to be reappraised. ## METHODS. In all, 89 __BRCA1/BRCA2__ mutation carriers underwent SO between 1994–2004. Past medical and familial history, SO, results and su

Prophylactic salpingo-oophorectomy in a
Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
✍ Niraj N. Mahajan πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 30 KB

Prophylactic Salpingo-Oophorectomy in a Series of 89 Women Carrying a BRCA1 or a BRCA2 Mutation I read with great interest the article published in Cancer by Laki et al. 1 and strongly support that prophylactic salpingo-oophorectomy (SO) is an important option for BRCA1/2 mutation carriers, as asymp

Reply to prophylactic salpingo-oophorect
Reply to prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
✍ Fatima Laki; Remy Salmon; Dominique Stoppa-Lyonnet πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 30 KB

Prophylactic Salpingo-Oophorectomy in a Series of 89 Women Carrying a BRCA1 or a BRCA2 Mutation I read with great interest the article published in Cancer by Laki et al. 1 and strongly support that prophylactic salpingo-oophorectomy (SO) is an important option for BRCA1/2 mutation carriers, as asymp